Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Prostatic Neoplasms 12Leukemia 12Lymphoma 7Burkitt Lymphoma 7Leukemia, Biphenotypic, Acute 6Lymphoma, Large B-Cell, Diffuse 5Recurrence 4Lymphoma, Non-Hodgkin 4Pituitary Neoplasms 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, B-Cell 3Leukemia, Myeloid, Acute 3Hodgkin Disease 3Rhabdoid Tumor 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Obesity 2Neoplasms 2Multiple Myeloma 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Hematologic Neoplasms 2Radiodermatitis 1Pyloric Stenosis, Hypertrophic 1Plasmablastic Lymphoma 1Pituitary Diseases 1Pinealoma 1

Interventions

Pancreaticoduodenectomy 4pasireotide 1glubran 2 1Serum Albumin, Human 1Radiosurgery 1Polygeline 1Pancreaticojejunostomy 1Neoprene 1Laparotomy 1Hydrocortisone 1Anti-Bacterial Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic Fistula × Hydrocortisone × Clear all
NCT02775227 2020-08-24

HYPAR

Helsinki University Central Hospital

Phase 4 Active not recruiting
126 enrolled
Gastrointestinal

Pancreatic Fistula, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡